[HTML][HTML] Histone deacetylases (HDACs): evolution, specificity, role in transcriptional complexes, and pharmacological actionability

G Milazzo, D Mercatelli, G Di Muzio, L Triboli… - Genes, 2020 - mdpi.com
Histone deacetylases (HDACs) are evolutionary conserved enzymes which operate by
removing acetyl groups from histones and other protein regulatory factors, with functional …

How do lncRNAs regulate transcription?

Y Long, X Wang, DT Youmans, TR Cech - Science advances, 2017 - science.org
It has recently become apparent that RNA, itself the product of transcription, is a major
regulator of the transcriptional process. In particular, long noncoding RNAs (lncRNAs) …

PRC2 is high maintenance

JR Yu, CH Lee, O Oksuz, JM Stafford… - Genes & …, 2019 - genesdev.cshlp.org
As the process that silences gene expression ensues during development, the stage is set
for the activity of Polycomb-repressive complex 2 (PRC2) to maintain these repressed gene …

Cell cycle transcription control: DREAM/MuvB and RB-E2F complexes

M Fischer, GA Müller - Critical reviews in biochemistry and …, 2017 - Taylor & Francis
The precise timing of cell cycle gene expression is critical for the control of cell proliferation;
de-regulation of this timing promotes the formation of cancer and leads to defects during …

Histone deacetylase complexes: Structure, regulation and function

MD Asmamaw, A He, LR Zhang, HM Liu… - Biochimica et Biophysica …, 2024 - Elsevier
Histone deacetylases (HDACs) are key epigenetic regulators, and transcriptional complexes
with deacetylase function are among the epigenetic corepressor complexes in the nucleus …

[HTML][HTML] Roles of histone deacetylases and inhibitors in anticancer therapy

FA Verza, U Das, AL Fachin, JR Dimmock, M Marins - Cancers, 2020 - mdpi.com
Histones are the main structural proteins of eukaryotic chromatin. Histone acetylation/
deacetylation are the epigenetic mechanisms of the regulation of gene expression and are …

Targeting class I histone deacetylases in a “complex” environment

CJ Millard, PJ Watson, L Fairall… - Trends in pharmacological …, 2017 - cell.com
Histone deacetylase (HDAC) inhibitors are proven anticancer therapeutics and have
potential in the treatment of many other diseases including HIV infection, Alzheimer's …

Unique structural platforms of Suz12 dictate distinct classes of PRC2 for chromatin binding

S Chen, L Jiao, M Shubbar, X Yang, X Liu - Molecular cell, 2018 - cell.com
Developmentally regulated accessory subunits dictate PRC2 function. Here, we report the
crystal structures of a 120 kDa heterotetrameric complex consisting of Suz12, Rbbp4, Jarid2 …

Characterization of histone deacetylase mechanisms in cancer development

R Hai, L He, G Shu, G Yin - Frontiers in oncology, 2021 - frontiersin.org
Over decades of studies, accumulating evidence has suggested that epigenetic
dysregulation is a hallmark of tumours. Post-translational modifications of histones are …

Rational targeting of a NuRD subcomplex guided by comprehensive in situ mutagenesis

F Sher, M Hossain, D Seruggia, VAC Schoonenberg… - Nature …, 2019 - nature.com
Developmental silencing of fetal globins serves as both a paradigm of spatiotemporal gene
regulation and an opportunity for therapeutic intervention of β-hemoglobinopathy. The …